Use of Basiliximab in Recipients Who Required Dose Reduction or Discontinuation of Calcineurin Inhibitors Early After Lung Transplantation

Autor: Y. Morimura, S. Tanaka, H. Kayawake, Y. Yamada, Y. Yutaka, A. Ohsumi, D. Nakajima, M. Hamaji, H. Date
Rok vydání: 2022
Předmět:
Zdroj: The Journal of Heart and Lung Transplantation. 41:S528
ISSN: 1053-2498
DOI: 10.1016/j.healun.2022.01.1339
Databáze: OpenAIRE